October 2006


Cell Genesys Inc. said Tuesday that Joseph Vallner, its president and chief operating officer, quit to take the top job at another company.
Japanese regulators approved the marketing of BioMarin Pharmaceutical Inc.'s Aldurazyme treatment for an enzyme deficiency in that country.
CV Therapeutics Inc. on Tuesday reported a third-quarter loss of $62.7 million, or $1.23 a share, compared to a loss of $55.9 million, or $1.26 a share in the same period last year.
Watson Pharmaceuticals said federal regulators have approved its purchase of Andrx Corp. The drug company said it expects the deal to close by Friday.
Money Mailer has entered the Houston market.

Next Page »

Hair Loss Product - Myspace Codes - Augmentation Breast Photo Recovery - New Mexico Breast Enlargement - Herbalife